ArticleJournal of neuro-oncology2016

Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.

Shamik Chakraborty et al.PubMed ↗Publisher ↗

No numbers read from the abstract.